Adequate surgery for papillary thyroid cancer

Surgeon

Volumn 7, Issue 5, 2009, Pages 286-289

  Elaraj, D M ^a   Sturgeon, C ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

extent of surgery; lymph node dissection; lymphadenectomy; papillary thyroid cancer

Indexed keywords

HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; METHODOLOGY; PAPILLARY CARCINOMA; REVIEW; THYROID TUMOR; THYROIDECTOMY;

CARCINOMA, PAPILLARY; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 71049131248     PISSN: 1479666X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1479-666X(09)80006-1     Document Type: Review

References (55)

1. Hundahl S.A., Fleming I.D., Fremgen A.M., et al. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer 15 12 (1998) 2638-2648 83
2. Shoup M., Stojadinovic A., Nissan A., et al. Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma. J Am Coll Surg 197 2 (2003) 191-197
3. Shaha A.R., Shah J.P., and Loree T.R. Low-risk differentiated thyroid cancer: the need for selective treatment. Ann Surg Oncol 4 4 (1997) 328-333
4. Mazzaferri E.L., and Jhiang S.M. Long-term impact of initial surgical and medical therapy on papillary and folli-cular thyroid cancer. Am J Med 97 5 (1994) 418-428
5. Hay I.D., Grant C.S., Taylor W.F., et al. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 102 6 (1987) 1088-1095
6. Hay I.D., Bergstralh E.J., Goellner J.R., et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114 6 (1993) 1050-1057 discussion
7. Hay I.D., Bergstralh E.J., Goellner J.R., et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114 6 (1993) 7-8
8. Hay I.D., Grant C.S., Bergstralh E.J., et al. Unilateral total lobectomy: is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma?. Surgery 124 6 (1998) 958-964 discussion
9. Hay I.D., Grant C.S., Bergstralh E.J., et al. Unilateral total lobectomy: is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma?. Surgery 124 6 (1998) 64-66
10. Lee S.H., Lee S.S., Jin S.M., et al. Predictive factors for central compartment lymph node metastasis in thyroid papillary microcarcinoma. Laryngoscope 118 4 (2008) 659-662
11. Palestini N., Borasi A., Cestino L., et al. Is central neck dissection a safe procedure in the treatment of papillary thyroid cancer? Our experience. Langenbecks Arch Surg (2008 Jul 1)
12. White M.L., Gauger P.G., and Doherty G.M. Central lymph node dissection in differentiated thyroid cancer. World J Surg 31 5 (2007) 895-904
13. Davies L., and Welch H.G. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 10 18 (2006) 2164-2167 2 95
14. Bilimoria K.Y., Bentrem D.J., Ko C.Y., et al. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 246 3 (2007) 375-381 discussion
15. Bilimoria K.Y., Bentrem D.J., Ko C.Y., et al. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 246 3 (2007) 81-84S
16. Hundahl S.A., Cady B., Cunningham M.P., et al. Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the united states during 1996. U.S. and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation study. Cancer 89 1 (2000) 202-217
17. Sosa J.A., Bowman H.M., Tielsch J.M., et al. The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg 228 3 (1998) 320-330
18. Russell W.O., Ibanez M.L., Clark R.L., et al. Thyroid carcinoma. Classification, intraglandular dissemination, and clinicopathological study based upon whole organ sections of 80 glands. Cancer 16 (1963) 1425-1460
19. Katoh R., Sasaki J., Kurihara H., et al. Multiple thyroid involvement (intraglandular metastasis) in papillary thyroid carcinoma. A clinicopathologic study of 105 consecutive patients. Cancer 70 6 (1992) 1585-1590
20. Samaan N.A., Maheshwari Y.K., Nader S., et al. Impact of therapy for differentiated carcinoma of the thyroid: an analysis of 706 cases. J Clin Endocrinol Metab 56 6 (1983) 1131-1138
21. Cady B., Sedgwick C.E., Meissner W.A., et al. Risk factor analysis in differentiated thyroid cancer. Cancer 43 3 (1979) 810-820
22. Haigh P.I., Urbach D.R., and Rotstein L.E. Extent of thyroi-dectomy is not a major determinant of survival in low- or high-risk papillary thyroid cancer. Ann Surg Oncol 12 1 (2005) 81-89
23. Wanebo H., Coburn M., Teates D., et al. Total thyroidec-tomy does not enhance disease control or survival even in high-risk patients with differentiated thyroid cancer. Ann Surg 227 6 (1998) 912-921
24. Sanders L.E., and Cady B. Differentiated thyroid cancer: reexamination of risk groups and outcome of treatment. Arch Surg 133 4 (1998) 419-425
25. Hay I.D., Grant C.S., van Heerden J.A., et al. Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery 112 6 (1992) 1139-1146 discussion
26. Hay I.D., Grant C.S., van Heerden J.A., et al. Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery 112 6 (1992) 46-47
27. Udelsman R., and Shaha A.R. Is total thyroidectomy the best possible surgical management for well-differentiated thyroid cancer?. Lancet Oncol 6 7 (2005) 529-531
28. Bilimoria K.Y., Bentrem D.J., Linn J.G., et al. Utilization of total thyroidectomy for papillary thyroid cancer in the United States. Surgery 142 6 (2007) 906-913 discussion
29. Bilimoria K.Y., Bentrem D.J., Linn J.G., et al. Utilization of total thyroidectomy for papillary thyroid cancer in the United States. Surgery 142 6 (2007) 13e1 13e2
30. Robbins K.T., Clayman G., Levine P.A., et al. Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery. Arch Otolaryngol Head Neck Surg 128 7 (2002) 751-758
31. Machens A., Holzhausen H.J., and Dralle H. Skip metas-tases in thyroid cancer leaping the central lymph node compartment. Arch Surg 39 1 (2004) 43-45
32. Noguchi S., Noguchi A., and Murakami N. Papillary carcinoma of the thyroid. I. Developing pattern of metastasis. Cancer 26 5 (1970 Nov) 1053-1060
33. Attie J.N., Khafif R.A., and Steckler R.M. Elective neck dissection in papillary carcinoma of the thyroid. Am J Surg 122 4 (1971) 464-471
34. Shindo M., Wu J.C., Park E.E., et al. The importance of central compartment elective lymph node excision in the staging and treatment of papillary thyroid cancer. Arch Otolaryngol Head Neck Surg 132 6 (2006) 650-654
35. Ito Y., Jikuzono T., Higashiyama T., et al. Clinical significance of lymph node metastasis of thyroid papillary carcinoma located in one lobe. J Surg 30 10 (2006) 1821-1828
36. Pereira J.A., Jimeno J., Miquel J., et al. Nodal yield, morbidity, and recurrence after central neck dissection for papillary thyroid carcinoma. Surgery 138 6 (2005) 1095-1100 discussion
37. Pereira J.A., Jimeno J., Miquel J., et al. Nodal yield, morbidity, and recurrence after central neck dissection for papillary thyroid carcinoma. Surgery 138 6 (2005) 100-101
38. Ito Y., Higashiyama T., Takamura Y., et al. Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection. J Surg 31 11 (2007) 2085-2091
39. Kouvaraki M.A., Shapiro S.E., Fornage B.D., et al. Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. Surgery 134 6 (2003) 946-954 discussion
40. Kouvaraki M.A., Shapiro S.E., Fornage B.D., et al. Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. Surgery 134 6 (2003) 54-55
41. I to Y., and Miyauchi A. Lateral and mediastinal lymph node dissection in differentiated thyroid carcinoma: indications, benefits, and risks. J Surg 31 5 (2007) 905-915
42. Cooper D.S., Doherty G.M., Haugen B.R., et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16 2 (2006) 109-142
43. Sherman S., Angelos P., Ball D., et al. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: Thyroid Carcinoma v.2.2007 (2007). http://www.nccn.org/professionals/physician_gls/PDF/thyroid.pdf [cited 2008 June 12]; available from
44. Mazzaferri E.L., and Kloos R.T. Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 86 4 (2001 Apr) 1447-1463
45. Simon D., Goretzki P.E., Witte J., et al. Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma. J Surg 20 7 (1996) 860-866 discussion
46. Simon D., Goretzki P.E., Witte J., et al. Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma. J Surg 20 7 (1996) 6
47. Harwood J., Clark O.H., and Dunphy J.E. Significance of lymph node metastasis in differentiated thyroid cancer. Am J Surg 136 1 (1978) 107-112
48. Toniato A., Boschin I., Casara D., et al. Papillary thyroid carcinoma: factors influencing recurrence and survival. Ann Surg Oncol 15 5 (2008) 1518-1522
49. Cady B., and Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 104 6 (1988) 947-953
50. Byar D.P., Green S.B., Dor P., et al., Thyroid Cancer Cooperative Group. A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Eur J Cancer 15 8 (1979) 1033-1041
51. Thyroid. In: Greene F., Page D., Fleming I., Fritz A., Balch C., Haller D., et al. (Eds). AJCC Cancer Staging Handbook. 6th ed. (2002), Springer-Verlag, New York 89-98
52. Xing M., Westra W.H., Tufano R.P., et al. BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. J Clin Endocrinol Metab 90 12 (2005) 6373-6379
53. Moreno-Egea A., Rodriguez-Gonzalez J.M., Sola-Perez J., et al. Multivariate analysis of histopathological features as prognostic factors in patients with papillary thyroid carcinoma. Br J Surg 82 8 (1995) 1092-1094
54. Sywak M., Pasieka J.L., and Ogilvie T. A review of thyroid cancer with intermediate differentiation. J Surg Oncol 86 1 (2004) 44-54
55. Henry J.F., Gramatica L., Denizot A., et al. Morbidity of prophylactic lymph node dissection in the central neck area in patients with papillary thyroid carcinoma. Langenbeck's Archives of Surgery/Deutsche Gesellschaft fur Chirurgie 383 2 (1998) 167-169